Ref.: BL-RE-092351Manufacturer ref.: EH375RBX5 5 x 96 tests
€2,950.00 excl. VAT
Human Podoplanin quantitates human Podoplanin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Podoplanin.
Accession number
Domaine intracellulaire de la podoplanine cytosolique de 29 kDa ; Aggrus ; CTA-520D8.1 ; E11 ; épitope d’antigène E11 ; antigène protéique transmembranaire de surface cellulaire épithéliale ; glycoprotéine 36 ; glycoprotéine 38 ; glycoprotéine, 36-KD ; GP36 ; Gp38 ; GP40 ; HT1A-1 ; hT1alpha-1 ; HT1alpha-2 ; glycoprotéine associée à la membrane cellulaire de type I du poumon ; glycoprotéine associée à la membrane cellulaire de type I du poumon (T1A-2) ; Ots8 ; OTS-8 ; OTTHUMP00000009640 ; OTTHUMP00000044504 ; PA2.26 ; antigène PA2.26 ; PDPN ; PICD ; podoplanine ; PSEC0003 ; PSEC0025 ; marqueur de différenciation transmembranaire des cellules épithéliales alvéolaires de type I pulmonaires ; RANDAM-2 ; RP23-348F1.2 ; RTI140 ; RTI40 ; T1A ; T1A2 ; T1A-2 ; T1alpha ; T1-alpha ; TI1A ; glycoprotéine transmembranaire E11 ; protéine de 40 kDa de cellule de type I
Dose range
0.16 to 40 ng/ml
Sensitivity of the dosage
0.16 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human Podoplanin quantitates human Podoplanin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Podoplanin.
Human Podoplanin quantitates human Podoplanin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Podoplanin.
Podoplanin (PDPN, T1A, gp38, Aggrus) is a type-1 glycoprotein mucin with a molecular weight of 40-43 kDa. Podoplanin is expressed in many normal tumours and cells, particularly in lymphatic epithelial cells and follicular DC cells. Podoplanin is located in the stromal cells of peripheral lymphoid tissues and thymic epithelial cells. Podoplanin, as a regulator of lymphatic endothelium, probably plays a role in maintaining the unique shape of podocytes. Podoplanin appears to be used as a ligand for CLEC-2 and its expression is positively correlated with tumours expressing greater invasive and metastatic potential. Podoplanin is directly involved in cell migration, facilitates the formation of metastases and the invasion of tumour cells in tissues. In addition, it has also been determined that the expression of podoplanin is induced by the Src activation of Case and, recently, indications of the presence of podoplanin on Th17 cells have been found. The first studies below indicate the presence of podoplanin in a small but distinct population of CD4+ cells from human PBMC. The dysfunction of the podoplanin protein is related to diseases such as lymphangioma and subglottic neoplasm. Podoplanin was also proposed as a marker for lung damage due to the physiological function of the protein.
Sensitivity
Sensitivity of dosage: 0.16 ng/ml.
Measurement range
Dosing range: 0.16 to 40 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Podoplanin.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; Serum, 50 µl; Plasma, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17185149
Specifications
Accession number
Intracellular domain of cytosolic podoplanin of 29 kDa; Aggrus; CTA-520D8.1; E11; epitope of E11 antigen; transmembrane protein antigen of epithelial cell surface; glycoprotein 36; glycoprotein 38; glycoprotein 36-KD; GP36; Gp38; GP40; HT1A-1; hT1alpha-1; HT1a